<SEC-DOCUMENT>0001193125-18-049470-index.html : 20180220
<SEC-HEADER>0001193125-18-049470.hdr.sgml : 20180220
<ACCEPTANCE-DATETIME>20180220061333
ACCESSION NUMBER:		0001193125-18-049470
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20180213
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
ITEM INFORMATION:		Changes in Control of Registrant
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180220
DATE AS OF CHANGE:		20180220

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35285
		FILM NUMBER:		18622921

	BUSINESS ADDRESS:	
		STREET 1:		395 OYSTER POINT BLVD., SUITE 405
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		395 OYSTER POINT BLVD., SUITE 405
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d536843d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: d536843d8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d536843dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
Document 2 - file: d536843dex31.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>d536843dex32.htm
<DESCRIPTION>EX-3.2
<TEXT>
Document 3 - file: d536843dex32.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>d536843dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
Document 4 - file: d536843dex101.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>d536843dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
Document 5 - file: d536843dex102.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>d536843dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
Document 6 - file: d536843dex103.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>7
<FILENAME>d536843dex161.htm
<DESCRIPTION>EX-16.1
<TEXT>
Document 7 - file: d536843dex161.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>d536843dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 8 - file: d536843dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g536843001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 9 - file: g536843001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g536843002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: g536843002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g536843vaxart10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: g536843vaxart10.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g536843vaxart11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 12 - file: g536843vaxart11.jpg

</DOCUMENT>
</SEC-DOCUMENT>